ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis-Reference-Cited by-同舟云学术

ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis

Published:2024-05-10 Issue:8 Volume:59 Page:709-718
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Atsukawa Masanori,Tsubota Akihito,Kondo Chisa,Toyoda Hidenori,Takaguchi Koichi,Nakamuta Makoto,Watanabe Tsunamasa,Morishita Asahiro,Tani Joji,Okubo Hironao,Hiraoka Atsushi,Nozaki Akito,Chuma Makoto,Kawata Kazuhito,Uojima Haruki,Ogawa Chikara,Asano Toru,Mikami Shigeru,Kato Keizo,Matsuura Kentaro,Ikegami Tadashi,Ishikawa Toru,Tsuji Kunihiko,Tada Toshifumi,Tsutsui Akemi,Senoh Tomonori,Kitamura Michika,Okubo Tomomi,Arai Taeang,Kohjima Motoyuki,Morita Kiyoshi,Akahane Takehiro,Nishikawa Hiroki,Iwasa Motoh,Tanaka Yasuhito,Iwakiri Katsuhiko

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00535-024-02109-8.pdf

Reference28 articles.

1. Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008;134:1715–28.

2. Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. J Gastroenterol. 2021;56:593–619.

3. Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res. 2021;51:725–49.

4. Yoshida H, Shimizu T, Yoshioka M, Taniai N. Management of portal hypertension based on portal hemodynamics. Hepatol Res. 2021;51:251–62.

5. Enomoto H, Ueno Y, Hiasa Y, et al. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan. J Gastroenterol. 2021;56:158–67.